Tandem Historical Balance Sheet

TNDM Stock

USD 19.81 0.41 2.03%

Trend analysis of Tandem Diabetes Care balance sheet accounts such as Total Stockholder Equity of 170 M, Other Liab of 43.6 M, Property Plant And Equipment Net of 171.6 M or Net Debt of 424.5 M provides information on Tandem Diabetes' total assets, liabilities, and equity, which is the actual value of Tandem Diabetes Care to its prevalent stockholders. By breaking down trends over time using Tandem Diabetes balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Tandem Diabetes Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tandem Diabetes Care is a good buy for the upcoming year.

Tandem Diabetes Inventory

157.09 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About Tandem Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tandem Diabetes Care at a specified time, usually calculated after every quarter, six months, or one year. Tandem Diabetes Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tandem Diabetes and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tandem currently owns. An asset can also be divided into two categories, current and non-current.

Tandem Diabetes Balance Sheet Chart

At this time, Tandem Diabetes' Net Debt is very stable compared to the past year. As of the 27th of March 2025, Non Current Assets Total is likely to grow to about 255.3 M, though Retained Earnings are likely to grow to (995.4 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Tandem Diabetes assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tandem Diabetes Care books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tandem Diabetes balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tandem Diabetes Care are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Tandem Diabetes' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tandem Diabetes Care current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	419.9M	415.7M	473.6M	497.2M
Total Assets	1.1B	952.7M	967.7M	1.0B

Short Long Term Debt Total Total Assets

Tandem Diabetes balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.96	0.85	0.93	0.87	0.98	0.95	0.91	-0.88	0.78	0.63	0.93	0.61	0.7	0.92	0.99	0.19	0.84	0.91	0.94	0.93	0.89	0.89	0.96	0.9	0.94
Short Long Term Debt Total	0.96		0.87	0.95	0.73	0.96	0.97	0.98	-0.87	0.76	0.53	0.97	0.62	0.66	0.81	0.95	0.09	0.7	0.81	0.98	0.96	0.91	0.8	0.99	0.96	0.85
Other Current Liab	0.85	0.87		0.97	0.58	0.9	0.86	0.88	-0.88	0.59	0.33	0.91	0.33	0.56	0.62	0.87	0.06	0.69	0.63	0.83	0.91	0.93	0.72	0.89	0.9	0.67
Total Current Liabilities	0.93	0.95	0.97		0.69	0.96	0.95	0.94	-0.94	0.75	0.43	0.97	0.53	0.59	0.73	0.94	0.05	0.78	0.74	0.91	0.98	0.93	0.82	0.96	0.97	0.79
Total Stockholder Equity	0.87	0.73	0.58	0.69		0.81	0.73	0.61	-0.73	0.72	0.75	0.66	0.5	0.65	0.97	0.87	0.34	0.9	0.94	0.69	0.69	0.66	0.91	0.7	0.62	0.95
Other Liab	0.98	0.96	0.9	0.96	0.81		0.95	0.94	-0.93	0.77	0.52	0.94	0.58	0.71	0.86	0.99	0.17	0.83	0.87	0.94	0.95	0.93	0.88	0.96	0.92	0.89
Property Plant And Equipment Net	0.95	0.97	0.86	0.95	0.73	0.95		0.93	-0.88	0.81	0.57	0.99	0.67	0.59	0.79	0.93	0.04	0.75	0.78	0.95	0.98	0.84	0.82	0.97	0.98	0.84
Net Debt	0.91	0.98	0.88	0.94	0.61	0.94	0.93		-0.85	0.71	0.33	0.95	0.61	0.63	0.72	0.91	0.05	0.64	0.75	0.97	0.95	0.93	0.73	0.98	0.94	0.77
Retained Earnings	-0.88	-0.87	-0.88	-0.94	-0.73	-0.93	-0.88	-0.85		-0.83	-0.42	-0.89	-0.55	-0.63	-0.72	-0.91	-0.13	-0.84	-0.73	-0.8	-0.93	-0.87	-0.91	-0.86	-0.88	-0.78
Accounts Payable	0.78	0.76	0.59	0.75	0.72	0.77	0.81	0.71	-0.83		0.5	0.77	0.7	0.42	0.73	0.79	-0.07	0.77	0.72	0.72	0.78	0.59	0.87	0.74	0.77	0.79
Cash	0.63	0.53	0.33	0.43	0.75	0.52	0.57	0.33	-0.42	0.5		0.5	0.31	0.42	0.71	0.57	0.23	0.52	0.59	0.49	0.45	0.32	0.59	0.48	0.45	0.67
Non Current Assets Total	0.93	0.97	0.91	0.97	0.66	0.94	0.99	0.95	-0.89	0.77	0.5		0.61	0.58	0.72	0.92	0.01	0.69	0.72	0.95	0.98	0.88	0.77	0.98	0.99	0.78
Non Currrent Assets Other	0.61	0.62	0.33	0.53	0.5	0.58	0.67	0.61	-0.55	0.7	0.31	0.61		0.33	0.56	0.58	-0.13	0.49	0.58	0.65	0.67	0.43	0.58	0.62	0.65	0.62
Other Assets	0.7	0.66	0.56	0.59	0.65	0.71	0.59	0.63	-0.63	0.42	0.42	0.58	0.33		0.69	0.7	0.76	0.61	0.69	0.65	0.61	0.66	0.66	0.64	0.52	0.68
Cash And Short Term Investments	0.92	0.81	0.62	0.73	0.97	0.86	0.79	0.72	-0.72	0.73	0.71	0.72	0.56	0.69		0.9	0.32	0.88	0.99	0.81	0.74	0.73	0.89	0.8	0.69	0.99
Net Receivables	0.99	0.95	0.87	0.94	0.87	0.99	0.93	0.91	-0.91	0.79	0.57	0.92	0.58	0.7	0.9		0.18	0.87	0.91	0.92	0.93	0.9	0.9	0.95	0.89	0.93
Common Stock Total Equity	0.19	0.09	0.06	0.05	0.34	0.17	0.04	0.05	-0.13	-0.07	0.23	0.01	-0.13	0.76	0.32	0.18		0.29	0.31	0.09	0.05	0.18	0.24	0.08	-0.06	0.27
Common Stock Shares Outstanding	0.84	0.7	0.69	0.78	0.9	0.83	0.75	0.64	-0.84	0.77	0.52	0.69	0.49	0.61	0.88	0.87	0.29		0.89	0.68	0.74	0.7	0.95	0.72	0.67	0.9
Short Term Investments	0.91	0.81	0.63	0.74	0.94	0.87	0.78	0.75	-0.73	0.72	0.59	0.72	0.58	0.69	0.99	0.91	0.31	0.89		0.81	0.74	0.76	0.89	0.81	0.69	0.98
Non Current Liabilities Total	0.94	0.98	0.83	0.91	0.69	0.94	0.95	0.97	-0.8	0.72	0.49	0.95	0.65	0.65	0.81	0.92	0.09	0.68	0.81		0.93	0.88	0.74	0.99	0.94	0.84
Inventory	0.93	0.96	0.91	0.98	0.69	0.95	0.98	0.95	-0.93	0.78	0.45	0.98	0.67	0.61	0.74	0.93	0.05	0.74	0.74	0.93		0.9	0.82	0.97	0.99	0.8
Other Current Assets	0.89	0.91	0.93	0.93	0.66	0.93	0.84	0.93	-0.87	0.59	0.32	0.88	0.43	0.66	0.73	0.9	0.18	0.7	0.76	0.88	0.9		0.76	0.92	0.87	0.76
Other Stockholder Equity	0.89	0.8	0.72	0.82	0.91	0.88	0.82	0.73	-0.91	0.87	0.59	0.77	0.58	0.66	0.89	0.9	0.24	0.95	0.89	0.74	0.82	0.76		0.78	0.75	0.93
Total Liab	0.96	0.99	0.89	0.96	0.7	0.96	0.97	0.98	-0.86	0.74	0.48	0.98	0.62	0.64	0.8	0.95	0.08	0.72	0.81	0.99	0.97	0.92	0.78		0.96	0.84
Property Plant And Equipment Gross	0.9	0.96	0.9	0.97	0.62	0.92	0.98	0.94	-0.88	0.77	0.45	0.99	0.65	0.52	0.69	0.89	-0.06	0.67	0.69	0.94	0.99	0.87	0.75	0.96		0.75
Total Current Assets	0.94	0.85	0.67	0.79	0.95	0.89	0.84	0.77	-0.78	0.79	0.67	0.78	0.62	0.68	0.99	0.93	0.27	0.9	0.98	0.84	0.8	0.76	0.93	0.84	0.75

Click cells to compare fundamentals

Tandem Diabetes Account Relationship Matchups

Tandem Diabetes balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	716.4M	905.1M	1.1B	952.7M	967.7M	1.0B
Short Long Term Debt Total	228.3M	314.7M	419.9M	415.7M	473.6M	497.2M
Other Current Liab	61.1M	75.1M	64.5M	84.6M	172.3M	180.9M
Total Current Liabilities	103.9M	131.9M	165.3M	195.3M	247.0M	259.4M
Total Stockholder Equity	366.3M	433.1M	439.9M	313.6M	263.1M	170.0M
Other Liab	17.7M	27.4M	34.8M	36.1M	41.5M	43.6M
Property Plant And Equipment Net	69.8M	77.9M	179.2M	164.3M	163.5M	171.6M
Net Debt	133.7M	243.5M	247.4M	356.8M	404.3M	424.5M
Retained Earnings	(659.2M)	(634.6M)	(729.2M)	(951.8M)	(1.0B)	(995.4M)
Accounts Payable	17.8M	28.0M	55.7M	49.6M	44.7M	26.1M
Cash	94.6M	71.2M	172.5M	58.9M	69.2M	66.2M
Non Current Assets Total	79.2M	93.6M	202.8M	204.7M	243.2M	255.3M
Non Currrent Assets Other	580K	9.1M	19.0M	37.6M	4.2M	7.1M
Other Assets	708K	29.2M	9.1M	10.7M	12.3M	12.9M
Cash And Short Term Investments	484.9M	623.8M	616.9M	467.9M	438.3M	259.2M
Net Receivables	82.2M	110.7M	114.7M	105.6M	114.6M	120.3M
Common Stock Total Equity	59K	14.3M	64K	65K	74.8K	71.0K
Common Stock Shares Outstanding	61.0M	64.3M	64.1M	65.0M	65.5M	34.6M
Short Term Investments	390.3M	552.6M	444.4M	409.0M	369.1M	193.0M
Liabilities And Stockholders Equity	716.4M	905.1M	1.1B	952.7M	967.7M	1.0B
Non Current Liabilities Total	246.3M	340.2M	447.5M	443.8M	457.5M	480.4M
Inventory	63.7M	68.6M	111.1M	157.9M	149.6M	157.1M
Other Current Assets	12.8M	16.9M	7.2M	16.6M	22.0M	23.1M
Other Stockholder Equity	1.0B	1.1B	1.2B	1.3B	1.3B	725.1M
Total Liab	350.1M	472.0M	612.8M	639.0M	704.6M	739.8M
Property Plant And Equipment Gross	50.0M	77.9M	179.2M	217.1M	226.3M	237.6M
Total Current Assets	637.2M	811.5M	850.0M	748.0M	724.5M	375.2M
Accumulated Other Comprehensive Income	220K	(616K)	(1.8M)	1.4M	(1.9M)	(2.0M)
Short Term Debt	18.8M	18.6M	26.2M	17.1M	18.2M	29.2M
Common Stock	62K	64K	65K	66K	75.9K	43.8K
Property Plant Equipment	32.9M	50.0M	50.4M	68.6M	78.8M	82.8M
Current Deferred Revenue	6.1M	10.2M	18.8M	44.0M	11.8M	9.5M
Intangible Assets	8.8M	6.6M	4.6M	2.8M	925K	878.8K
Net Tangible Assets	195.0M	366.3M	433.1M	439.9M	505.9M	531.2M
Retained Earnings Total Equity	(624.8M)	(659.2M)	(634.6M)	(729.2M)	(656.3M)	(689.1M)
Capital Surpluse	819.6M	1.0B	1.1B	1.2B	1.3B	776.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:

How To Invest In Tandem

Details

Is Tandem Stock a good investment?

Details

What is Tandem Diabetes' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.37)

Earnings Share

(1.43)

Revenue Per Share

14.365

Quarterly Revenue Growth

0.436

Return On Assets

(0.06)

The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tandem Historical Balance Sheet

Tandem Diabetes Inventory

157.09 Million

About Tandem Balance Sheet Analysis

Tandem Diabetes Balance Sheet Chart

Total Assets

Total Current Liabilities

Tandem Diabetes balance sheet Correlations

Tandem Diabetes Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tandem Diabetes balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total
Net Receivables	+ 0.99	Other Liab
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Short Term Investments	+ 0.99	Cash And Short Term Investments

Retained Earnings	- 0.94	Total Current Liabilities
Inventory	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Other Liab
Other Stockholder Equity	- 0.91	Retained Earnings
Net Receivables	- 0.91	Retained Earnings
Non Current Assets Total	- 0.89	Retained Earnings